Long-Term Safety and Efficacy of the Anti-Madcam Monoclonal Antibody Shp647 for the Treatment of Crohn's Disease: The Opera II Study

Authors
Category Primary study
JournalGastroenterology
Year 2018
This article has no abstract
Epistemonikos ID: 051f4b4eea9f3a117735a60fedc51fe443558bac
First added on: Mar 23, 2022